Eco-Friendly and Ethical Sourcing
Production from yeast completely eliminates reliance on shark liver oil , supporting marine conservation and ethical practices.
Squalane is a saturated hydrocarbon widely prized in the cosmetics and pharmaceutical industries for its excellent emollient, moisturizing, and skin penetration properties. Historically, the precursor, Squalene, was sourced from shark liver oil, a practice that shark extraction damages ecology and is ethically untenable. While chemical synthesis and plant extraction are alternatives, they suffer from high cost for chemical synthesis and yield low concentration. Biosynthesis offers a scalable, eco-friendly, and cost-effective alternative by producing Squalene from simple sugars, followed by enzymatic conversion to Squalane.
CD Biosynsis offers a synthetic biology service focused on high-yield Squalane production using Saccharomyces cerevisiae (baker's yeast). Our core strategy involves modification of squalene synthesis pathway in Saccharomyces cerevisiae . Squalene is naturally synthesized via the highly regulated Mevalonate (MVA) pathway. We maximize Squalene accumulation by overexpressing key MVA pathway enzymes (e.g., tHMG1) and Squalene Synthase (ERG9) while deleting or downregulating pathways that consume Squalene (e.g., conversion to Ergosterol). This is coupled with heterologous expression of hydrogenase . Squalane is derived by the saturation (hydrogenation) of Squalene's six double bonds. We introduce a heterologous, NADPH-dependent Hydrogenase (e.g., from a specific microbial source) into the engineered yeast strain. This enzyme catalyzes the conversion of Squalene to the stable, fully saturated Squalane product in a single, clean enzymatic step. This integrated approach bypasses destructive animal sourcing and the multi-step, high-energy requirements of chemical hydrogenation, delivering a sustainable, high-purity Squalane.
Get a QuoteSustainable and cost-effective Squalane production faces these key challenges:
A successful solution must shift the production away from animal sources, maximize Squalene yield, and enzymatically stabilize the final product.
CD Biosynsis utilizes advanced metabolic and enzyme engineering to optimize Squalane production in S. cerevisiae:
Modification of Squalene Synthesis Pathway in S. cerevisiae
We overexpress rate-limiting MVA enzymes (tHMG1) and Squalene Synthase (ERG9), while deleting Squalene Epoxidase (ERG1) , the enzyme that consumes Squalene to produce Ergosterol.
Heterologous Expression of Hydrogenase
We introduce a specific NADPH-dependent Hydrogenase that catalyzes the Squalene-to-Squalane conversion, offering a clean, metal-free hydrogenation step.
NADPH Cofactor Engineering
We co-express enzymes (e.g., G6PDH) to regenerate NADPH , the essential cofactor for the Hydrogenase enzyme, ensuring sustained catalytic activity.
Lipid Body Morphology Optimization
We engineer the strain to increase the size and capacity of lipid droplets (storage organelles), maximizing the storage capacity for the hydrophobic Squalane product.
This systematic approach ensures high Squalene precursor yield and its subsequent clean, enzymatic stabilization into Squalane.
Our Squalane engineering service is dedicated to pursuing the following production goals:
Eco-Friendly and Ethical Sourcing
Production from yeast completely eliminates reliance on shark liver oil , supporting marine conservation and ethical practices.
Clean, Metal-Free Hydrogenation
Enzymatic conversion avoids the use of expensive, high-pressure equipment and noble metal catalysts , lowering capital and operational costs.
High Product Stability
The final saturated Squalane is highly stable and resistant to oxidation , unlike the Squalene intermediate, ensuring long shelf life.
High Fermentation Titer
Metabolic engineering ensures a maximal diversion of carbon from sugar to the Squalene pathway, leading to high accumulation.
Food-Grade GRAS Host Icon
Using S. cerevisiae ensures the final product is compatible with cosmetic and health supplement regulatory standards .
We provide a sustainable and economically competitive biosynthetic route for high-quality Squalane.
Our Squalane strain engineering service follows a rigorous, multi-stage research workflow:
Technical communication is maintained throughout the process, focusing on timely feedback regarding yield and saturation efficiency.
Explore the potential for a stable, eco-friendly Squalane supply. CD Biosynsis provides customized strain and enzyme engineering solutions:
Why is Squalene converted to Squalane?
Squalene is highly reactive due to its six double bonds, making it unstable and prone to oxidation (rancidity). Converting it to the fully saturated Squalane drastically increases its stability, which is essential for cosmetic and pharmaceutical product shelf life.
What is the role of the ERG1 gene deletion?
The ERG1 gene encodes Squalene Epoxidase , which normally converts Squalene into Lanosterol on its way to making Ergosterol (the yeast equivalent of cholesterol). Deleting ERG1 is critical because it blocks this competing pathway , forcing Squalene to accumulate for subsequent conversion to Squalane.
How does enzymatic hydrogenation compare to chemical hydrogenation?
Enzymatic hydrogenation (using Hydrogenase) is a cleaner, milder process that occurs under atmospheric pressure and physiological pH. Chemical hydrogenation requires high temperature, high pressure, and toxic heavy metal catalysts , making it expensive and environmentally unfriendly.
Why is NADPH regeneration important?
The heterologous Hydrogenase enzyme uses NADPH as the source of reducing power (hydrogen) to saturate the double bonds of Squalene. Co-expressing NADPH regeneration enzymes ensures a continuous, high supply of NADPH , which is essential for sustaining the high conversion rate.
What is the estimated project timeline?
A project involving MVA pathway modification, ERG1 deletion, and heterologous Hydrogenase expression typically requires 22-26 weeks for final strain delivery and comprehensive performance validation.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.